PTPN12 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.571000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.859230E-01
Normal-vs-Stage2
7.398000E-01
Normal-vs-Stage3
4.581200E-01
Normal-vs-Stage4
3.233000E-01
Stage1-vs-Stage2
1.001630E-01
Stage1-vs-Stage3
8.277000E-01
Stage1-vs-Stage4
4.758300E-02
Stage2-vs-Stage3
2.480800E-01
Stage2-vs-Stage4
2.888600E-01
Stage3-vs-Stage4
1.545420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.023800E-01
Normal-vs-AfricanAmerican
8.726400E-01
Normal-vs-Asian
7.821000E-01
Caucasian-vs-AfricanAmerican
7.702200E-01
Caucasian-vs-Asian
8.047800E-01
AfricanAmerican-vs-Asian
6.197800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.429600E-01
Normal-vs-Female
8.752600E-01
Male-vs-Female
8.532600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.171600E-01
Normal-vs-Age(41-60Yrs)
5.046600E-01
Normal-vs-Age(61-80Yrs)
9.529600E-01
Normal-vs-Age(81-100Yrs)
9.506200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.186200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.001600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.895000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.283000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.740810E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.794000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.265000E-01
Normal-vs-Daily Drinker
8.842000E-01
Normal-vs-Weekly Drinker
9.669200E-01
Normal-vs-Occasional Drinker
1.904230E-01
Normal-vs-Social Drinker
8.450800E-01
Non Drinker-vs-Daily Drinker
6.244400E-01
Non Drinker-vs-Weekly Drinker
9.107600E-01
Non Drinker-vs-Occasional Drinker
3.183400E-01
Non Drinker-vs-Social Drinker
8.536400E-01
Daily Drinker-vs-Weekly Drinker
7.405600E-01
Daily Drinker-vs-Occasional Drinker
1.655980E-01
Daily Drinker-vs-Social Drinker
5.433000E-01
Weekly Drinker-vs-Occasional Drinker
3.203000E-01
Weekly Drinker-vs-Social Drinker
7.800400E-01
Occasional Drinker-vs-Social Drinker
4.837600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.336600E-01
Normal-vs-Grade 2
1.077700E-02
Normal-vs-Grade 3
3.633600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.62030000000679E-06
Grade 1-vs-Grade 3
4.09839999999662E-05
Grade 1-vs-Grade 4
2.336600E-01
Grade 2-vs-Grade 3
2.163800E-01
Grade 2-vs-Grade 4
1.077700E-02
Grade 3-vs-Grade 4
3.633600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.294600E-01
Normal-vs-NonDiabetic
8.010600E-01
Diabetic-vs-NonDiabetic
1.513210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.710400E-01
Normal-vs-NoPancreatitis
8.769000E-01
Pancreatitis-vs-NoPancreatitis
4.186000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.798800E-01
Normal-vs-N1
7.656800E-01
N0-vs-N1
3.649600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.064100E-02
Normal-vs-TP53-NonMutant
1.101170E-01
TP53-Mutant-vs-TP53-NonMutant
4.1838999999988E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
